Why Cancer Defies Classification | Anya Plutynski
Why It Matters
Recognizing cancer’s fluid classification is essential for designing precise therapies and for guiding AI tools that could otherwise mislead treatment decisions.
Key Takeaways
- •Cancer classification lacks a tidy clear hierarchical structure.
- •Genetic features often overlap across different tumor types.
- •Tumors evolve, altering their molecular profile over time.
- •Microenvironment and systemic factors shape cancer behavior beyond genetics.
- •AI integrates massive genomic data but faces interpretability and bias risks.
Summary
The video with Anya Plutynski explores why cancer resists traditional, tidy classification, contrasting the classic tissue‑of‑origin taxonomy with newer molecular approaches. She explains that genetic mutations frequently cross boundaries between cancers, that tumors are dynamic populations evolving under treatment pressure, and that overlapping phenotypic and genotypic traits blur hierarchical categories. Plutynski cites the Cancer Genome Atlas’s finding that pancreatic and lung cancers can share mutations, notes sex‑specific incidence patterns, and highlights AI efforts to sort “genomic amounts of data” while warning about black‑box pitfalls. The discussion underscores that effective diagnosis and therapy require a pluralistic framework combining genetics, microenvironment, and systemic factors, and that clinicians must balance AI‑driven insights with interpretability to avoid over‑treatment.
Comments
Want to join the conversation?
Loading comments...